Surrozen, Inc. (SRZN) Financials
SRZN Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| 2023-09-30 | 54.0 million | 8.4 million |
| 2023-06-30 | 64.0 million | 8.9 million |
| 2023-03-31 | 74.2 million | 11.2 million |
| 2022-12-31 | 89.4 million | 13.4 million |
SRZN Free Cash Flow and Stock based compensation
Graph available only for supporters. Become a supporter to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| 2023-09-30 | -10.1 million | 913000 |
| 2023-06-30 | -8.8 million | 1.2 million |
| 2023-03-31 | -14.5 million | 1.1 million |
| 2022-12-31 | -353000 | 1.5 million |
SRZN Net Income
No data available :(
SRZN Cash and Debt
Graph available only for supporters. Become a supporter to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| 2023-09-30 | 43.4 million | - | 4.0 million |
| 2023-06-30 | 53.4 million | - | 4.5 million |
| 2023-03-31 | 61.7 million | - | 5.1 million |
| 2022-12-31 | 75.8 million | - | 5.6 million |
SRZN Shares Outstanding
SRZN Expenses
Graph available only for supporters. Become a supporter to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| 2023-09-30 | - | 6.1 million | 3.6 million | - |
| 2023-06-30 | 83000 | 6.9 million | 3.3 million | - |
| 2023-03-31 | 315000 | 8.1 million | 5.3 million | - |
| 2022-12-31 | 148000 | 9.4 million | 5.2 million | - |
SRZN Cost of Revenue
Graph available only for supporters. Become a supporter to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| 2023-09-30 | - | 483000 |
| 2023-06-30 | - | 807000 |
| 2023-03-31 | - | 783000 |
| 2022-12-31 | 12.5 million | 768000 |
SRZN
Price: $10.76
52 week price:
Earnings Per Share: -19.75 USD
P/E Ratio: -0.51
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Volume: 41336
Market Capitalization: 22.6 million